6:06 PM
 | 
Sep 04, 2007
 |  BC Extra  |  Company News

ABT terminates icatibant license

Kos, a subsidiary of Abbott (ABT), terminated an agreement that gave it North American rights to icatibant from Jerini (FSE:JI4). Jerini now has worldwide rights to the selective...

Read the full 140 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >